BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 6091156)

  • 1. [Drug permeation through artificial lipid membranes. 17. The mechanism of ion pair transport].
    Neubert R; Fürst W; Böhm W; Dabow S
    Pharmazie; 1984 Jun; 39(6):401-3. PubMed ID: 6091156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug permeation through synthetic lipid membranes. Part 13: The effects of tensides on the permeation of ionized drugs (author's transl)].
    Fürst W; Neubert R; Förster B; Reppel L
    Pharmazie; 1980; 34(5-6):315-6. PubMed ID: 7413708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug transport through artificial lipoid membranes. 21. Ion pair transport with alkyl salicylic acids].
    Neubert R; Fürst W; Schleiermacher H; Bergmann P; Stolte E
    Pharmazie; 1987 May; 42(5):309-11. PubMed ID: 3671439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quasi-equilibrium analysis of the ion-pair mediated membrane transport of low-permeability drugs.
    Miller JM; Dahan A; Gupta D; Varghese S; Amidon GL
    J Control Release; 2009 Jul; 137(1):31-7. PubMed ID: 19264104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug permeation through synthetic lipoid membranes. 18. The mechanism of ion-pair permeation proton countertransport].
    Neubert R; Fürst W; Schleiermacher H
    Pharmazie; 1985 Jun; 40(6):426-7. PubMed ID: 4034654
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug permeation through artificial lipoid membranes. 2. Mathematical description of substance transport].
    Falk M; Fürst W
    Pharmazie; 1973; 28(11):765-8. PubMed ID: 4791265
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanism of the action of tenside on permeation through lipid membranes].
    Falk M
    Pharmazie; 1988 Apr; 43(4):256-8. PubMed ID: 3413213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SC lipid model membranes designed for studying impact of ceramide species on drug diffusion and permeation--part II: diffusion and permeation of model drugs.
    Ochalek M; Podhaisky H; Ruettinger HH; Wohlrab J; Neubert RH
    Eur J Pharm Biopharm; 2012 Oct; 82(2):360-6. PubMed ID: 22750439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug permeation through synthetic lipid membranes. 11. Various membrane types used in permeation and absorption models].
    Fürst W; Neubert R; Richter H; Reppel L
    Pharmazie; 1980 Feb; 35(2):120-1. PubMed ID: 7384181
    [No Abstract]   [Full Text] [Related]  

  • 10. Permeation characteristics of a hydrophilic basic compound across a bio-mimetic artificial membrane.
    Sugano K; Nabuchi Y; Machida M; Asoh Y
    Int J Pharm; 2004 May; 275(1-2):271-8. PubMed ID: 15081157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced in vitro skin permeation of cationic drugs.
    Green PG; Hadgraft J; Ridout G
    Pharm Res; 1989 Jul; 6(7):628-32. PubMed ID: 2798314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug permeability through artificial lipid membranes. 15: Effect of anions on the transport of buformin in model membranes and isolated, lumen- and vessel-perfused small intestine].
    Mothes T; Neubert R; Fürst W
    Pharmazie; 1983 Jan; 38(1):46-7. PubMed ID: 6844381
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug permeation through synthetic lipid membranes. Part 10: The effects of diffusion layers on the permeation process (author's transl)].
    Fürst W; Neubert R; Reppel L
    Pharmazie; 1980 Feb; 35(2):106-9. PubMed ID: 7384178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protonophoretic activity of hypoglycemic sulfonylureas in black lipid membranes.
    Deleers M; Brasseur R
    Pharmacol Res Commun; 1986 Feb; 18(2):129-36. PubMed ID: 3010341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug permeation through membranes. I. Effect of various substances on amobarbital permeation through polydimethylsiloxane.
    Lovering EG; Black DB
    J Pharm Sci; 1973 Apr; 62(4):602-6. PubMed ID: 4698980
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blockaders of ion channels formed in a lipid bilayer by polyene antibiotics].
    Borisova MP; Ermishkin LN; Zil'bershteĭn AIa
    Biofizika; 1978; 23(6):1093-4. PubMed ID: 719026
    [No Abstract]   [Full Text] [Related]  

  • 17. An in vitro collodion-lipid membrane model for drug absorption studies.
    Brandys J; Kwiek J; Witek J
    Pol J Pharmacol Pharm; 1974; 26(5):519-26. PubMed ID: 4427813
    [No Abstract]   [Full Text] [Related]  

  • 18. Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interaction with biological membranes.
    Mason RP; Rhodes DG; Herbette LG
    J Med Chem; 1991 Mar; 34(3):869-77. PubMed ID: 2002467
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of lipophilic counter-ions on membrane diffusion of benzydamine.
    Sarveiya V; Templeton JF; Benson HA
    Eur J Pharm Sci; 2005 Sep; 26(1):39-46. PubMed ID: 15950443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of transcorneal permeation of pilocarpine.
    Mitra AK; Mikkelson TJ
    J Pharm Sci; 1988 Sep; 77(9):771-5. PubMed ID: 3225772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.